Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +35.93%
#2 Siren Siren +30.58%
#3 Purr Purr +28.58%
#4 OriginTrail OriginTrail +23.69%
#5 ApeX ApeX +17.69%
#6 UnifAI Network UnifAI Network +16.61%
#7 Wrapped XPL Wrapped XPL +16.15%
#8 Plasma Plasma +16.04%
#9 Unit Plasma Unit Plasma +16.04%
#10 Pendle Pendle +15.57%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Polaryx Therapeutics, Inc. Common Stock Polaryx Therapeutics, Inc. Common Stock

Polaryx Therapeutics, Inc. Common Stock

PLYX
Rang in Aktien #21586
Polaryx Therapeutics, Inc. functions as a biotechnology firm dedicated to... Polaryx Therapeutics, Inc. functions as a biotechnology firm dedicated to advancing small-molecule therapies for lysosomal storage and neurodegenerative conditions. Its developmental pipeline includes a trio of promising candidates: PLX-100, which combines PLX-200 with an ancillary supplement, targeting late infantile neuronal ceroid lipofuscinosis (LINCL) and related forms of NCL. PLX-200, a repurposed compound already utilized to address various diseases in both adult and pediatric populations. And PLX-300, derived from an edible plant, which works by activating PPARa to enhance the production of transcription factor EB. The company, established in 2014, maintains its base of operations in Paramus, New Jersey.
Aktienkurs
$2.10
Zuletzt synchronisiert: 2026-08-21
Marktkapitalisierung
$104.43M
Veränderung (1 Tag)
-2.10%
Veränderung (1 Jahr)
-
Land
US
Handel Polaryx Therapeutics, Inc. Common Stock (PLYX)

Kategorie

Healthcare
P/S-Verhältnis für Polaryx Therapeutics, Inc. Common Stock (PLYX)
P/S-Verhältnis zum 2026 TTM: 0
Laut den neuesten Finanzberichten und dem Aktienkurs von Polaryx Therapeutics, Inc. Common Stock beträgt das aktuelle Kurs-Umsatz-Verhältnis (TTM) 0. Am Ende des Jahres 2026 lag das P/S-Verhältnis bei 0.
P/S-Verlauf für Polaryx Therapeutics, Inc. Common Stock von 2026 bis 2026
P/S-Verhältnis zum Jahresende
Jahr P/S-Verhältnis ändert
Nicht genügend Daten für die angegebenen Daten.
P/S-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/S-Verhältnis P/S-Verhältnis-Differenz Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH